Click
Chat
 
Du kan vedhæfte PDF, JPG, PNG, DOC(X), XLS(X) og TXT-filer. Klik på ikonet, vælg fil og vent til upload er færdig før du indsender eller uploader endnu en fil.
60
Vedhæft Send
DANMARKS STØRSTE INVESTORSITE MED DEBAT, CHAT OG NYHEDER

Fluoguide - precli data on FG001 effect in treatment cancer


96271 iskh 23/8 2021 13:50
Oversigt

Copenhagen, Denmark, 23 August 2021. FluoGuide A/S ("FluoGuide" or the "Company") is pleased to announce the first publication of preclinical data where the Company's compound FG001 is used as a photothermal therapy agent for treatment of cancer. The new feature of FG001 complements the surgical targeting and opens new opportunities for the realization of clinical and commercial potential of the Company's uPAR-targeting technology platform.

Link/Full details:
https://news.cision.com/fluoguide/r/publication-of-promising-preclinical-data-on-fg001s-effect-in-treatment-of-cancer,c3401276

Publication:
https://www.oncotarget.com/article/28013/pdf/



25/8 2021 16:55 iskh 096376



Q2 2021 - Regnskab - præsentation - YouTube




25/8 2021 16:57 iskh 096377



(PDF) Q2 2021 Regnskab og highlights for Fluoguide:
https://fluoguide.com/wp-content/uploads/FluoGuide-Q2-2021-report-Final.pdf



TRÅDOVERSIGT